Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2020 Filed Mar 2, 2020 13:10 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 161 | $8.73 | $1,405.53 |
DisclosureSEC source: 0001104659-20-027510 · tm2011386d1_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,824 F1 · balance_after: Includes 74,663 shares of restricted stock. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 21:53 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 10,000 | $9.31 | $93,100.00 |
DisclosureSEC source: 0001104659-20-024813 · tm2010943d1_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,663 F1 · balance_after: Includes 74,663 shares of restricted stock. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 21:55 UTC |
Vazzano Joseph WalterChief Financial Officer
|
PurchaseCommon Stock | 1,200 | $9.09 | $10,908.00 |
DisclosureSEC source: 0001104659-20-024815 · tm2010943d12_4.xml · nonDerivative · entry 1 Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,863 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 21:31 UTC |
Lu LucyDirector · President, CEO
|
GrantRestricted Stock Units · Derivative | 110,959 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-020235 · tm208004-1_form4.xml · derivative · entry 1 Lu Lucy · CIK 0001542419 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,576 Underlying: Common Stock · 110,959 shares Expires 2025-02-12 F1 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 21:32 UTC |
Vazzano Joseph WalterChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 22,727 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-020237 · tm208004-2_form4.xml · derivative · entry 1 Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,505 Underlying: Common Stock · 22,727 shares Expires 2025-02-12 F1 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 16:16 UTC |
Ingram Elizabeth GarrettDirector
|
PurchaseCommon Stock | 16,000 | $6.27 | $100,320.00 |
DisclosureSEC source: 0001144204-19-044714 · tv529486_form4.xml · nonDerivative · entry 1 Ingram Elizabeth Garrett · CIK 0001743688 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 16:17 UTC |
KRANZLER JAY DDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-042094 · tv528434_form4.xml · nonDerivative · entry 1 KRANZLER JAY D · CIK 0001055666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,663 F1 · shares: Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 20:17 UTC |
Herskowitz NeilDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-042093 · tv528433_form4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,663 F1 · shares: Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 20:19 UTC |
Vazzano Joseph WalterChief Financial Officer
|
SaleCommon Stock | 2,375 | $5.56 | $13,205.00 |
DisclosureSEC source: 0001144204-19-039191 · tv527358_4.xml · nonDerivative · entry 2 Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,663 F2 · price: On August 9, 2019, a total of 2,375 shares were sold by the Company at a weighted average sales price of $5.56 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 20:19 UTC |
Vazzano Joseph WalterChief Financial Officer
|
SaleCommon Stock | 2,313 | $5.62 | $12,999.06 |
DisclosureSEC source: 0001144204-19-039191 · tv527358_4.xml · nonDerivative · entry 1 Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,038 F1 · price: On August 8, 2019, a total of 2,313 shares were sold by the Company at a weighted average sales price of $5.62 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 20:54 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 2,000 | $5.83 | $11,660.00 |
DisclosureSEC source: 0001144204-19-031499 · tv523735_4.xml · nonDerivative · entry 2 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,663 F1 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 20:54 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 3,000 | $5.88 | $17,640.00 |
DisclosureSEC source: 0001144204-19-031499 · tv523735_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,663 F1 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:41 UTC |
Lu LucyDirector · President, CEO
|
GrantRestricted Stock Units · Derivative | 135,617 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-029899 · tv523097_form4.xml · derivative · entry 1 Lu Lucy · CIK 0001542419 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,617 Underlying: Common Stock · 135,617 shares Expires 2024-06-03 F1 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:42 UTC |
Vazzano Joseph WalterChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 27,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-029900 · tv523099_form4.xml · derivative · entry 1 Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,778 Underlying: Common Stock · 27,778 shares Expires 2024-06-03 F1 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen. Read SEC document |
| April 15, 2019 Filed Apr 15, 2019 20:33 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 1,000 | $4.52 | $4,520.00 |
DisclosureSEC source: 0001144204-19-019691 · tv518915_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,663 F1 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| March 29, 2019 Filed Mar 29, 2019 20:33 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 1,400 | $5.11 | $7,154.00 |
DisclosureSEC source: 0001144204-19-017010 · tv517581_4.xml · nonDerivative · entry 2 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,663 F1 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 20:33 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 600 | $5.11 | $3,066.00 |
DisclosureSEC source: 0001144204-19-017010 · tv517581_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,263 F1 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| February 25, 2019 Filed Feb 25, 2019 21:13 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 5,000 | $5.46 | $27,300.00 |
DisclosureSEC source: 0001144204-19-009857 · tv512626_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,663 F1 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 21:31 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 1,850 | $5.77 | $10,674.50 |
DisclosureSEC source: 0001144204-19-005339 · tv512626_form4.xml · nonDerivative · entry 2 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,663 F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:31 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 7,000 | $5.91 | $41,370.00 |
DisclosureSEC source: 0001144204-19-005339 · tv512626_form4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,813 F1 · price: Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on February 4, 2019 was $5.90 to $5.97. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 17:48 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 650 | $5.91 | $3,841.50 |
DisclosureSEC source: 0001144204-19-004355 · tv512263_form4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,813 F1 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 21:18 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 8,553 | $5.91 | $50,548.23 |
DisclosureSEC source: 0001144204-19-003774 · tv512042_form4.xml · nonDerivative · entry 2 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,163 F1 · price: Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on January 28, 2019 was $5.82 to $5.89 and the range of prices for the purchase transactions on January 29, 2019 was $5.86 to $5.99. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 21:18 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 1,447 | $5.84 | $8,450.48 |
DisclosureSEC source: 0001144204-19-003774 · tv512042_form4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,610 F1 · price: Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on January 28, 2019 was $5.82 to $5.89 and the range of prices for the purchase transactions on January 29, 2019 was $5.86 to $5.99. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 13:15 UTC |
Paley JeffreyDirector
|
PurchaseCommon Stock | 5,000 | $4.76 | $23,800.00 |
DisclosureSEC source: 0001144204-18-064217 · tv508813_form4.xml · nonDerivative · entry 2 Paley Jeffrey · CIK 0001595327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,663 F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| December 03, 2018 Filed Dec 12, 2018 13:15 UTC |
Paley JeffreyDirector
|
PurchaseCommon Stock | 10,000 | $5.48 | $54,754.00 |
DisclosureSEC source: 0001144204-18-064217 · tv508813_form4.xml · nonDerivative · entry 1 Paley Jeffrey · CIK 0001595327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,663 F1 · price: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on December 3, 2018 was $5.4734 to $5.4774. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 01:46 UTC |
ROSENWALD LINDSAY A MDDirector
|
GiftCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042960 · tv500469_form4.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,663 F1 · shares: The 14,663 shares of restricted common stock will vest on August 7, 2021. F2 · balance_after: Includes 24,663 shares of restricted stock. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 21:43 UTC |
KRANZLER JAY DDirector
|
GiftCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042956 · tv500467_form4.xml · nonDerivative · entry 1 KRANZLER JAY D · CIK 0001055666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,663 F1 · shares: The 14,663 shares of restricted common stock will vest on August 7, 2021. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 21:40 UTC |
WEISS MICHAEL SDirector
|
GiftCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042952 · tv500465_form4.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,663 F1 · shares: The 14,663 shares of restricted common stock will vest on August 7, 2021. F2 · balance_after: Includes 24,663 shares of restricted stock. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 01:45 UTC |
Herskowitz NeilDirector
|
GiftCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042958 · tv500468_form4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,163 F1 · shares: The 14,663 shares of restricted common stock will vest on August 7, 2021. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 01:48 UTC |
Lu LucyDirector · President, CEO
|
GiftCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042962 · tv500470_form4.xml · nonDerivative · entry 1 Lu Lucy · CIK 0001542419 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,333 F1 · shares: The 250,000 shares of restricted common stock will vest as follows: one-fourth on August 7, 2019, one-fourth on August 7, 2020, one-fourth on August 7, 2021, and one-fourth on August 7, 2022. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 21:39 UTC |
Paley JeffreyDirector
|
GiftCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042950 · tv500464_form4.xml · nonDerivative · entry 1 Paley Jeffrey · CIK 0001595327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,663 F1 · shares: The 14,663 shares of restricted common stock will vest on August 7, 2021. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 01:50 UTC |
Vazzano Joseph WalterVP Finance & Corp. Controller
|
GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042965 · tv500471_form4.xml · nonDerivative · entry 1 Vazzano Joseph Walter · CIK 0001715291 · VP Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,351 F1 · shares: The 30,000 shares of restricted common stock will vest as follows: one-fourth on August 7, 2019, one-fourth on August 7, 2020, one-fourth on August 7, 2021, and one-fourth on August 7, 2022. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 01:37 UTC |
SAMAD AKHTARDirector
|
GiftCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042948 · tv500463_form4.xml · nonDerivative · entry 1 SAMAD AKHTAR · CIK 0001645047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,663 F1 · shares: The 14,663 shares of restricted common stock will vest on August 7, 2021. F2 · balance_after: Includes 64,663 shares of restricted stock. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 01:42 UTC |
Reines ScottInterim Chief Medical Officer
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-042954 · tv500466_form4.xml · nonDerivative · entry 1 Reines Scott · CIK 0001716401 · Interim Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F1 · shares: The 10,000 shares of restricted common stock will vest as follows: one-fourth on August 7, 2019, one-fourth on August 7, 2020, one-fourth on August 7, 2021, and one-fourth on August 7, 2022. Read SEC document |
| June 28, 2018 Filed Jun 28, 2018 17:09 UTC |
Vazzano Joseph WalterVP Finance & Corp. Controller
|
GrantCommon Stock | 1,351 | $3.66 | $4,944.66 |
DisclosureSEC source: 0001144204-18-036289 · tv497535_form4.xml · nonDerivative · entry 1 Vazzano Joseph Walter · CIK 0001715291 · VP Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,351 Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 17:19 UTC |
Lu LucyDirector · President, CEO
|
GrantCommon Stock | 5,000 | $4.00 | $20,000.00 |
DisclosureSEC source: 0001144204-18-034375 · tv496576_form4.xml · nonDerivative · entry 1 Lu Lucy · CIK 0001542419 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,333 Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 21:37 UTC |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 5,234 | $4.34 | $22,715.56 |
DisclosureSEC source: 0001144204-18-033791 · tv496320_form4.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,234 F1 · price: Weighted average price. These shares were purchased in multiple transactions ranging from $4.20 to $4.40. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth. F2 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 21:31 UTC Amendment |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 5,234 | $4.34 | $22,726.55 |
DisclosureSEC source: 0001144204-18-033938 · tv496382_form4a.xml · nonDerivative · entry 6 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| June 07, 2018 Filed Jun 12, 2018 21:31 UTC Amendment |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 14,800 | $4.32 | $63,968.56 |
DisclosureSEC source: 0001144204-18-033938 · tv496382_form4a.xml · nonDerivative · entry 5 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,766 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| June 06, 2018 Filed Jun 12, 2018 21:31 UTC Amendment |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 9,100 | $4.35 | $39,575.90 |
DisclosureSEC source: 0001144204-18-033938 · tv496382_form4a.xml · nonDerivative · entry 4 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,966 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| June 05, 2018 Filed Jun 12, 2018 21:31 UTC Amendment |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 8,400 | $4.28 | $35,948.64 |
DisclosureSEC source: 0001144204-18-033938 · tv496382_form4a.xml · nonDerivative · entry 3 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,866 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| June 04, 2018 Filed Jun 12, 2018 21:31 UTC Amendment |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 3,800 | $4.19 | $15,920.86 |
DisclosureSEC source: 0001144204-18-033938 · tv496382_form4a.xml · nonDerivative · entry 2 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,466 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| June 01, 2018 Filed Jun 12, 2018 21:31 UTC Amendment |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 8,666 | $4.15 | $36,002.90 |
DisclosureSEC source: 0001144204-18-033938 · tv496382_form4a.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,666 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| April 25, 2018 Filed Apr 25, 2018 20:30 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 1,000 | $3.80 | $3,800.00 |
DisclosureSEC source: 0001144204-18-022402 · tv492043_form4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 F1 · balance_after: Includes 50,000 shares of restricted stock. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 16:19 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 1,000 | $5.01 | $5,010.00 |
DisclosureSEC source: 0001144204-17-052957 · tv477192_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,500 F1 · balance_after: Includes 50,000 shares of restricted stock. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 12:36 UTC |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 1,350 | $5.40 | $7,290.00 |
DisclosureSEC source: 0001144204-17-051784 · tv476670_form4.xml · nonDerivative · entry 4 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 12:27 UTC |
Herskowitz NeilDirector
|
PurchaseCommon Stock | 500 | $5.24 | $2,620.00 |
DisclosureSEC source: 0001144204-17-051782 · tv476706_4.xml · nonDerivative · entry 1 Herskowitz Neil · CIK 0001298246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,500 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| October 06, 2017 Filed Oct 10, 2017 12:36 UTC |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 2,900 | $5.63 | $16,327.00 |
DisclosureSEC source: 0001144204-17-051784 · tv476670_form4.xml · nonDerivative · entry 3 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,650 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 12:36 UTC |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 3,550 | $5.60 | $19,880.00 |
DisclosureSEC source: 0001144204-17-051784 · tv476670_form4.xml · nonDerivative · entry 2 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
| October 04, 2017 Filed Oct 10, 2017 12:36 UTC |
ROSENWALD LINDSAY A MDDirector
|
PurchaseCommon Stock | 2,200 | $5.60 | $12,320.00 |
DisclosureSEC source: 0001144204-17-051784 · tv476670_form4.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,200 F1 · balance_after: Includes 10,000 shares of restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.